OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022
Mark W. Tenforde, Wesley H. Self, Manjusha Gaglani, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 12, pp. 459-465
Open Access | Times Cited: 159
Mark W. Tenforde, Wesley H. Self, Manjusha Gaglani, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 12, pp. 459-465
Open Access | Times Cited: 159
Showing 1-25 of 159 citing articles:
Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study
Martina McMenamin, Joshua Nealon, Yun Lin, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 10, pp. 1435-1443
Open Access | Times Cited: 315
Martina McMenamin, Joshua Nealon, Yun Lin, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 10, pp. 1435-1443
Open Access | Times Cited: 315
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 213
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 213
Mortality Risk Among Patients Hospitalized Primarily for COVID-19 During the Omicron and Delta Variant Pandemic Periods — United States, April 2020–June 2022
Stacey Adjei, Kai Hong, Noelle‐Angelique Molinari, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 37, pp. 1182-1189
Open Access | Times Cited: 153
Stacey Adjei, Kai Hong, Noelle‐Angelique Molinari, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 37, pp. 1182-1189
Open Access | Times Cited: 153
COVID-19 Vaccination Coverage, by Race and Ethnicity — National Immunization Survey Adult COVID Module, United States, December 2020–November 2021
Jennifer L. Kriss, Mei-Chuan Hung, Anup Srivastav, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 23, pp. 757-763
Open Access | Times Cited: 138
Jennifer L. Kriss, Mei-Chuan Hung, Anup Srivastav, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 23, pp. 757-763
Open Access | Times Cited: 138
Factors Associated with Severe Outcomes Among Immunocompromised Adults Hospitalized for COVID-19 — COVID-NET, 10 States, March 2020–February 2022
Jason Robert C Singson, Pam Daily Kirley, Huong Pham, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 27, pp. 878-884
Open Access | Times Cited: 82
Jason Robert C Singson, Pam Daily Kirley, Huong Pham, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 27, pp. 878-884
Open Access | Times Cited: 82
Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization
Daniel R. Feikin, Laith J. Abu‐Raddad, Nick Andrews, et al.
Vaccine (2022) Vol. 40, Iss. 26, pp. 3516-3527
Open Access | Times Cited: 79
Daniel R. Feikin, Laith J. Abu‐Raddad, Nick Andrews, et al.
Vaccine (2022) Vol. 40, Iss. 26, pp. 3516-3527
Open Access | Times Cited: 79
IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein
Vladimir N. Uversky, Elrashdy M. Redwan, William Makis, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 991-991
Open Access | Times Cited: 78
Vladimir N. Uversky, Elrashdy M. Redwan, William Makis, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 991-991
Open Access | Times Cited: 78
Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods
Ruth Link‐Gelles, Matthew E. Levy, Karthik Natarajan, et al.
JAMA Network Open (2023) Vol. 6, Iss. 3, pp. e232598-e232598
Open Access | Times Cited: 65
Ruth Link‐Gelles, Matthew E. Levy, Karthik Natarajan, et al.
JAMA Network Open (2023) Vol. 6, Iss. 3, pp. e232598-e232598
Open Access | Times Cited: 65
mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications
Yu‐Shiuan Wang, Monika Kumari, Guanhong Chen, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 65
Yu‐Shiuan Wang, Monika Kumari, Guanhong Chen, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 65
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49
Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49
Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study
Nicole Ngai Yung Tsang, Hau Chi So, Benjamin J. Cowling, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 4, pp. 421-434
Open Access | Times Cited: 52
Nicole Ngai Yung Tsang, Hau Chi So, Benjamin J. Cowling, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 4, pp. 421-434
Open Access | Times Cited: 52
Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA
Michelle M. Mello, Douglas J. Opel, Regina M. Benjamin, et al.
The Lancet (2022) Vol. 400, Iss. 10351, pp. 535-538
Open Access | Times Cited: 51
Michelle M. Mello, Douglas J. Opel, Regina M. Benjamin, et al.
The Lancet (2022) Vol. 400, Iss. 10351, pp. 535-538
Open Access | Times Cited: 51
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period — IVY Network, 19 U.S. States, February 1, 2022–January 31, 2023
Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
MMWR Morbidity and Mortality Weekly Report (2023) Vol. 72, Iss. 17, pp. 463-468
Open Access | Times Cited: 31
Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
MMWR Morbidity and Mortality Weekly Report (2023) Vol. 72, Iss. 17, pp. 463-468
Open Access | Times Cited: 31
Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022
Brechje de Gier, Liselotte van Asten, Tjarda M. Boere, et al.
Vaccine (2023) Vol. 41, Iss. 31, pp. 4488-4496
Open Access | Times Cited: 29
Brechje de Gier, Liselotte van Asten, Tjarda M. Boere, et al.
Vaccine (2023) Vol. 41, Iss. 31, pp. 4488-4496
Open Access | Times Cited: 29
Effectiveness of SARS-CoV-2 vaccines against Omicron infection and severe events: a systematic review and meta-analysis of test-negative design studies
Shangchen Song, Zachary J. Madewell, Ming‐Jin Liu, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 29
Shangchen Song, Zachary J. Madewell, Ming‐Jin Liu, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 29
Estimation of Vaccine Effectiveness of CoronaVac and BNT162b2 Against Severe Outcomes Over Time Among Patients With SARS-CoV-2 Omicron
Yuchen Wei, Katherine Min Jia, Shi Zhao, et al.
JAMA Network Open (2023) Vol. 6, Iss. 2, pp. e2254777-e2254777
Open Access | Times Cited: 28
Yuchen Wei, Katherine Min Jia, Shi Zhao, et al.
JAMA Network Open (2023) Vol. 6, Iss. 2, pp. e2254777-e2254777
Open Access | Times Cited: 28
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021–August 2022
Noah Kojima, Katherine Adams, Wesley H. Self, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 4, pp. 547-557
Open Access | Times Cited: 26
Noah Kojima, Katherine Adams, Wesley H. Self, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 4, pp. 547-557
Open Access | Times Cited: 26
IgG4 Antibodies Induced by mRNA Vaccines Generate Immune Tolerance to SARS-CoV-2’spike Protein by Suppressing the Immune System
Vladimir N. Uversky, Elrashdy M. Redwan, William Makis, et al.
(2023)
Open Access | Times Cited: 21
Vladimir N. Uversky, Elrashdy M. Redwan, William Makis, et al.
(2023)
Open Access | Times Cited: 21
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations
Michael Westberg, Yichi Su, Xinzhi Zou, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 738
Open Access | Times Cited: 12
Michael Westberg, Yichi Su, Xinzhi Zou, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 738
Open Access | Times Cited: 12
Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection
Deborah E. Malden, In‐Lu Amy Liu, Lei Qian, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Deborah E. Malden, In‐Lu Amy Liu, Lei Qian, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave
Yumeko Kawano, Naomi J. Patel, Xiaosong Wang, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 12, pp. 1742-1749
Open Access | Times Cited: 35
Yumeko Kawano, Naomi J. Patel, Xiaosong Wang, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 12, pp. 1742-1749
Open Access | Times Cited: 35
Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study
Chiara Farroni, Alessandra Aiello, Andrea Picchianti Diamanti, et al.
International Journal of Infectious Diseases (2022) Vol. 125, pp. 195-208
Open Access | Times Cited: 32
Chiara Farroni, Alessandra Aiello, Andrea Picchianti Diamanti, et al.
International Journal of Infectious Diseases (2022) Vol. 125, pp. 195-208
Open Access | Times Cited: 32
Vaccine effectiveness of two and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong
Martina McMenamin, Joshua Nealon, Yun Lin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 31
Martina McMenamin, Joshua Nealon, Yun Lin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 31
Hospitalized Patients With Severe Coronavirus Disease 2019 During the Omicron Wave in Israel: Benefits of a Fourth Vaccine Dose
Tal Brosh‐Nissimov, Khetam Hussein, Yonit Wiener‐Well, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e234-e239
Open Access | Times Cited: 28
Tal Brosh‐Nissimov, Khetam Hussein, Yonit Wiener‐Well, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e234-e239
Open Access | Times Cited: 28
Effectiveness of COVID-19 Vaccines against SARS-CoV-2 Omicron Variant (B.1.1.529): A Systematic Review with Meta-Analysis and Meta-Regression
Nando Reza Pratama, Ifan Ali Wafa, David Setyo Budi, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2180-2180
Open Access | Times Cited: 27
Nando Reza Pratama, Ifan Ali Wafa, David Setyo Budi, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2180-2180
Open Access | Times Cited: 27
